98%
921
2 minutes
20
Obesity alters the adipose tissue (AT) immune microenvironment (TIME) and induces inflammation. Nevertheless, the specific time when TIME dysfunction emerges in AT remains elusive. Obesity mouse models were constructed and categorized into Lean (Ctrl), moderately obese (Mid_Ob, with body weight exceeding Ctrl by > 10%), and Obese (Ob, with body weight exceeding Ctrl by > 20%) groups. Single-nucleus RNA sequencing (snRNA-seq) and immunofluorescence localization were employed to analyze changes in cell populations, cluster marker genes, and signaling pathways in mouse epididymal white adipose tissue (eWAT). A total of 23,068 cells obtained from three mouse eWAT samples (Ctrl, Mid_Ob, and Ob) underwent snRNA-seq. Eighteen distinct clusters were identified, and seven cell types were annotated with representative markers. In-depth analysis unveiled the functions of the adipose AT-associated Krt23+fibroblast (ATAKF) cell subtype and refined the crosstalk hypothesis concerning ATAKFs, macrophages, and neutrophils. We further demonstrated that ATAKFs were present in the Mid_Ob group. Additionally, from the Mid_Ob to Ob stage, AT inflammatory factors, macrophages, and neutrophils significantly increased while neurons markedly decreased; however, these factors did not change significantly from the Ctrl to Mid_Ob stage. Cell-cell communication analysis revealed the central role of ATAKFs and their regulation of macrophages and neutrophils. Only when obesity reaches the Mid_Ob stage AT fibroblasts specifically express Krt23+, recruit neutrophils, and secrete CCL2, CCL6, and CCL9 to attract macrophages, thereby altering the eWAT TIME. ATAKFs contribute to immune microenvironment disorders during the development of mouse AT obesity. This study offers valuable resources and a foundation for understanding the timing of TIME dysfunction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323179 | PMC |
http://dx.doi.org/10.1186/s40001-025-02978-6 | DOI Listing |
J Biomed Sci
September 2025
Division of Gastroenterology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Oncometabolites are aberrant metabolic byproducts that arise from mutations in enzymes of the tricarboxylic acid (TCA) cycle or related metabolic pathways and play central roles in tumor progression and immune evasion. Among these, 2-hydroxyglutarate (2-HG), succinate, and fumarate are the most well-characterized, acting as competitive inhibitors of α-ketoglutarate-dependent dioxygenases to alter DNA and histone methylation, cellular differentiation, and hypoxia signaling. More recently, itaconate, an immunometabolite predominantly produced by activated macrophages, has been recognized for its dual roles in modulating inflammation and tumor immunity.
View Article and Find Full Text PDFNature
September 2025
Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Monocyte-derived macrophages (mo-macs) often drive immunosuppression in the tumour microenvironment (TME) and tumour-enhanced myelopoiesis in the bone marrow fuels these populations. Here we performed paired transcriptome and chromatin accessibility analysis over the continuum of myeloid progenitors, circulating monocytes and tumour-infiltrating mo-macs in mice and in patients with lung cancer to identify myeloid progenitor programs that fuel pro-tumorigenic mo-macs. We show that lung tumours prime accessibility for Nfe2l2 (NRF2) in bone marrow myeloid progenitors as a cytoprotective response to oxidative stress, enhancing myelopoiesis while dampening interferon response and promoting immunosuppression.
View Article and Find Full Text PDFOncogene
September 2025
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pancreatic cancer is a highly aggressive malignancy with a dismal prognosis, characterized by a complex tumor microenvironment that promotes immunosuppression and limits the efficacy of immune checkpoint blockade (ICB) therapy. Fibroblast activation protein (FAP) is overexpressed in the tumor stroma and represents a promising target for therapeutic intervention. Here, we developed a novel antibody-drug conjugate (ADC) targeting FAP, and investigated its anti-tumor activity and ability to enhance ICB efficacy in pancreatic cancer.
View Article and Find Full Text PDFUrol Oncol
September 2025
Nutritional, Genes and Human Disease Laboratory, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh. Electronic address:
Background: Understanding the mutational landscape is critical for elucidating the molecular mechanisms driving cancer progression. This study aimed to profile somatic mutations in bladder cancer patients (N=7) from Bangladesh to provide insights into the genetic alterations underlying this malignancy.
Methods: We performed targeted sequencing of 50 oncogenes and tumor suppressor genes using the Ion AmpliSeq Cancer Hotspot Panel v2 on tumor and matched blood samples from seven bladder cancer patients.
J Immunother Cancer
September 2025
Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA
Prostate cancer (PC) is notoriously known for exhibiting an immunologically cold phenotype in the tumor immune microenvironment (TIME), leading to the need for interventions to enhance immunotherapy efficacy. Recent findings by Zhao in the identified stromal monoamine oxidase A (MAOA), a key enzyme that degrades monoamine neurotransmitters and plays a role in the neuroendocrine system, as a critical regulator of the immune response to PC. Altering MAOA levels in myofibroblastic cancer-associated fibroblasts, either genetically or pharmacologically, can reprogram PC's TIME to modulate CD8 T cell-mediated cytotoxicity through the WNT5A-Ca²-NFATC1 signaling axis, highlighting the stromal influences on CD8 T cell cytotoxic activity within the TIME.
View Article and Find Full Text PDF